Biotech startups that raised Series A in France
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Biolevate | Paris | Series A | $34.4M | 2026-09-21 |
| Generare | Paris | Series A | $23.1M | 2026-04-02 |
| Bon Vivant | Lyon | Series A | $29.4M | 2026-02-24 |
| Adcytherix | Marseille | Series A | $122.8M | 2025-10-16 |
| Genomines | Paris | Series A | $45.0M | 2025-09-17 |
| Coave Therapeutics | Paris | Series A | $32.9M | 2025-01-09 |
| DeepLife | Vernon | Series A | $10.0M | 2024-12-11 |
| inHEART | Pessac | Series A | $811K | 2024-10-28 |
8 rows of the CSV in 5 of its 18 columns.
- The 76 biotech startups in France whose last round is Series A have raised $977.8M in total.
- 9 of them closed their most recent round in the last 12 months, $195.4M combined.
- The largest of those rounds is Biolevate's $34.4M Series A, dated September 2026.
- Bpifrance is an investor in 7 of them, more than any other fund.
- Health care is the most common other sector, with 55 companies (72%).
- 25% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 11 to 50 employees (63% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
10 of 76| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Biolevate | Biolevate provides an AI platform that helps life sciences teams run regulated operations with auditable workflows. | Artificial intelligence | Paris | Series A | $34.4M | 2026-09-21 | $40.7M | Bpifrance, EQT Ventures | 11 to 50 | 2024 |
| Generare | Generare discovers new medicines and valuable molecules from soil bacteria. | Artificial intelligence | Paris | Series A | $23.1M | 2026-04-02 | $32.2M | Better Angle, Teampact ventures, Galion.exe +1 | 11 to 50 | 2022 |
| Bon Vivant | Bon Vivant uses precision fermentation to produce real dairy products accessible to everyone. | Biotech | Lyon | Series A | $29.4M | 2026-02-24 | $59.6M | Kima Ventures, Picus Capital, Sofinnova Partners +1 | 11 to 50 | 2021 |
| Adcytherix | Adcytherix is a biopharmaceutical firm developing antibody drug conjugates. | Biotech | Marseille | Series A | $122.8M | 2025-10-16 | $155.1M | RA Capital Management, Pureos Bioventures, Pontifax +1 | 11 to 50 | 2023 |
| Genomines | Genomines is a biotechnology company that uses plants for mining. | Biotech | Paris | Series A | $45.0M | 2025-09-17 | $61.8M | Bpifrance, Elemental Impact, Lowercarbon Capital | 11 to 50 | 2021 |
| Bioptimus | Bioptimus builds a foundation AI model for biology to accelerate scientific discovery. | Artificial intelligence | Paris | Series A | $41.0M | 2025-01-14 | Bpifrance, Headline, Cathay Innovation +1 | 1 to 10 | 2024 | |
| HawkCell | HawkCell offers MRI solutions for veterinary clinics and preclinical research labs. | Biotech | Lyon | Series A | $5.5M | 2024-03-11 | $5.5M | Bpifrance, MIG Capital | 11 to 50 | 2018 |
| AbolerIS Pharma | AbolerIS Pharma develops immuno-modulators for transplant rejection, graft-versus-host disease, and autoimmune diseases. | Biotech | Nantes | Series A | $29.2M | 2023-09-18 | Criteria Venture Tech, Sound Bioventures, Turenne Groupe | 11 to 50 | 2019 | |
| Gradient Denervation Technologies | Gradient Denervation Technologies develops a transvascular medical device for treating pulmonary hypertension. | Biotech | Paris | Series A | $15.0M | 2023-09-07 | MedTech Innovator, Sofinnova Partners, Thuja Capital +1 | 11 to 50 | 2019 | |
| NGI | NGI is a creative advertising agency offering website development and graphic design services. | Biotech | Nantes | Series A | $11.8M | 2007-12-19 | Auriga Partners, Quest for Growth, Sanofi Ventures +1 | 11 to 50 | 2001 |
Table 1. Biotech startups that raised Series A in France: the 10 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 76.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Biolevate | Biolevate provides an AI platform that helps life sciences teams run regulated operations with auditable workflows. | Artificial intelligence | Paris | Series A | $34.4M | 2026-09-21 | $40.7M | Bpifrance, EQT Ventures | 11 to 50 | 2024 |
| 2 | Bon Vivant | Bon Vivant uses precision fermentation to produce real dairy products accessible to everyone. | Biotech | Lyon | Series A | $29.4M | 2026-02-24 | $59.6M | Kima Ventures, Picus Capital, Sofinnova Partners +1 | 11 to 50 | 2021 |
| 3 | Generare | Generare discovers new medicines and valuable molecules from soil bacteria. | Artificial intelligence | Paris | Series A | $23.1M | 2026-04-02 | $32.2M | Better Angle, Teampact ventures, Galion.exe +1 | 11 to 50 | 2022 |
Table 2. Biotech startups that raised Series A in France: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Bpifrance | Government investment office | Maisons-alfort, France | 7 | 9% | 1 | Biolevate |
| 2 | Kima Ventures | Micro VC fund | Paris, France | 2 | 3% | 1 | Bon Vivant |
| 3 | Sofinnova Partners | Venture capital firm | Paris, France | 2 | 3% | 1 | Bon Vivant |
| 4 | Pureos Bioventures | Venture capital firm | Küsnacht, Switzerland | 2 | 3% | ||
| 5 | Kurma Partners | Venture capital firm | Paris, France | 2 | 3% | ||
| 6 | Omnes Capital | Private equity firm | Paris, France | 2 | 3% | ||
| 7 | EQT Ventures | Venture capital firm | Stockholm, Sweden | 1 | 1% | 1 | Biolevate |
| 8 | VIVES Funds | Venture capital firm | Wavre, Belgium | 1 | 1% | 1 | Generare |
| 9 | Better Angle | Micro VC fund | Paris, France | 1 | 1% | 1 | Generare |
| 10 | Teampact ventures | Venture capital firm | Paris, France | 1 | 1% | 1 | Generare |
| 11 | Galion.exe | Venture capital firm | Paris, France | 1 | 1% | 1 | Generare |
| 12 | Founders Future | Private equity firm | San Francisco, United States | 1 | 1% | 1 | Bon Vivant |
| 13 | Picus Capital | Venture capital firm | Munich, Germany | 1 | 1% | 1 | Bon Vivant |
| 14 | RA Capital Management | Startup incubator | Boston, United States | 1 | 1% | ||
| 15 | Pontifax | Venture capital firm | Herzliya, Israel | 1 | 1% |
Table 3. Biotech startups that raised Series A in France: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 55 | 72% | $792.0M |
| Software | 11 | 14% | $81.4M |
| Artificial intelligence | 7 | 9% | $81.4M |
| Hardware | 4 | 5% | $3.2M |
| Education | 1 | 1% | $12.4M |
| Energy | 1 | 1% |
Table 4. Biotech startups that raised Series A in France by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 76 | 100% | $12.0M |
Table 5. Biotech startups that raised Series A in France by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Paris | 31 | 41% |
| Lyon | 10 | 13% |
| Marseille | 3 | 4% |
| Toulouse | 2 | 3% |
| Valbonne | 2 | 3% |
| Pessac | 2 | 3% |
| Évry | 2 | 3% |
| Nantes | 2 | 3% |
| Villeurbanne | 2 | 3% |
| Issoire | 1 | 1% |
| Dijon | 1 | 1% |
| Vandoeuvre-lès-nancy | 1 | 1% |
Table 6. Biotech startups that raised Series A in France by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| September 2026 | 1 | 11% | $34.4M |
| July 2026 | 1 | 11% | $12.6M |
| May 2026 | 1 | 11% | $23.5M |
| April 2026 | 1 | 11% | $23.1M |
| February 2026 | 1 | 11% | $29.4M |
| January 2026 | 3 | 33% | $51.5M |
| December 2025 | 1 | 11% | $20.9M |
Table 7. Biotech startups that raised Series A in France: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 8 | 11% | $174.5M |
| 2025 | 12 | 16% | $338.6M |
| 2024 | 10 | 13% | $88.5M |
| 2023 | 10 | 13% | $236.0M |
| 2022 | 6 | 8% | $108.2M |
| 2021 | 8 | 11% | $207.8M |
Table 8. Biotech startups that raised Series A in France by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 3 | 4% |
| 2020 to 2022 | 16 | 21% |
| 2015 to 2019 | 30 | 39% |
| 2010 to 2014 | 19 | 25% |
| Before 2010 | 8 | 11% |
Table 9. Biotech startups that raised Series A in France by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 25 | 33% |
| 11 to 50 | 48 | 63% |
| 51 to 100 | 2 | 3% |
| 101 to 250 | 1 | 1% |
Table 10. Biotech startups that raised Series A in France by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series A and its headquarters is in France. On 16 November 2026 that is 76 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 10 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 76 rows: 5 have no round amount, 0 no city and 20 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in France whose last round is Series A are on the list?
- 76, in the file dated 16 November 2026. 9 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 76 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.